Karen L. Parkhill - Jul 31, 2023 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & Chief Financial Officer
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol
MDT
Transactions as of
Jul 31, 2023
Transactions value $
$0
Form type
4
Date filed
8/2/2023, 07:43 PM
Previous filing
May 4, 2023
Next filing
Aug 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Award $0 +12.5K +39.32% $0.00 44.4K Jul 31, 2023 Direct F1, F2
holding MDT Ordinary Shares 49.9K Jul 31, 2023 Jeffrey S. Parkhill 2021 Irrevocable Trust F3
holding MDT Ordinary Shares 843 Jul 31, 2023 By Child #1
holding MDT Ordinary Shares 843 Jul 31, 2023 By Child #2
holding MDT Ordinary Shares 843 Jul 31, 2023 By Child #3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Performance Share Units Award $0 +31.3K $0.00 31.3K Jul 31, 2023 Performance Share Unit 31.3K Direct F4, F5, F6
transaction MDT Stock Option (Right to Buy) Award $0 +88.3K $0.00 88.3K Jul 31, 2023 Ordinary Shares 88.3K $87.76 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
F2 Includes 921 units acquired through dividend reinvestment since the last report filed by the reporting person.
F3 These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.
F4 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F5 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 31,336 shares will be issued. If maximum performance metrics are achieved, 62,672 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F6 Vests on July 31, 2026.
F7 These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant.